메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

호문사 (경상대학교, 경상대학교 대학원)

지도교수
김성희
발행연도
2017
저작권
경상대학교 논문은 저작권에 의해 보호받습니다.

이용수17

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
We evaluated the biological activities of water and ethanolic extracts of G. procumbens, M. charantia, C. longa, and H. tuberosus (Jerusalem artichoke) concentrate. The biological activities of five kinds of Jerusalem artichoke composites with addition of G. procumbens, M. charantia and C. longa extracts to H. tuberosus concentrate at different ratio were investigated. The best optimal composite was selected, and its hypoglycemic, antidiabetic and hypolipidemic effects were evaluated in streptozotocin(STZ)-induced diabetic rats in vivo.
Water and 70% ethanol extracts of G. procumbens, M. charantia and C. longa were prepared, and hot water extract of H. tuberosus was concentrated to 60 brix. Solids content was higher in ethanolic than water extract. The pH levels of extracts was slightly acidic except for ethanolic extract of C. longa. Contents of total phenolic and flavonoids showed no significant differences between water and ethanolic extracts, and contents were the highest in ethanolic extract of C. longa. Cholesterol adsorption activity was over 50% in M. charantia extract. DPPH and ABTS radical scavenging activities and reducing power were higher in ethanolic extract than water extract. Especially, the antioxidant activities of water extract of G. procumbens and ethanolic extract of C. longa were highest.
The in vitro, the antioxidant, α-glucosidase inhibitory, and hypoglycemic activities of the five type of Jerusalem artichoke composites in Chang cells were evaluated. DPPH and ABTS radical scavenging activities and reducing power were slightly higher in Comp-2 and Comp-3, was higher in composites with ethanolic extracts compared to water extracts. Especially, Comp-3 had significantly higher α-glucosidase inhibitory activity. Cell viability decreased in a dose-dependent manner in response to ethanol extracts of G. procumbens and C. longa whereas M. charantia, Jerusalem artichoke concentrate, and the five types of composites had no effect on cytotoxicity. AMPK protein activity increased in Comp-1, 2, 3, and 4. Especially, Comp-1 had the highest AMPK protein and glucose uptake activities. However, Comp-3 was selected as the most proper composite considering flavor, taste and contents of H. tuberosus, in the sensory evaluation.
The effects of Jerusalem artichoke composite (Comp-3) were investigated on the hypoglycemic, antidiabetic and lipid improvement status in streptozotocin (STZ)-induced diabetic rats. Rats were divided into seven groups: normal, diabetic control, group fed G. procumbens extract (500 mg/kg bw, D-PGE), group fed Jerusalem artichoke composites (0.5 g/kg bw, D-JAP1; 1.5 g/kg bw, D-JAP2), group fed Jerusalem artichoke concentrate (1.5 g/kg bw, D-JA) and group fed metformin(200 mg/kg bw, D-MET). Blood glucose level decreased in all experimental groups according to time period. Reduction of glucose level in the D-JAP2 and D-MET groups was higher compared to other groups. In the oral glucose tolerance test (OGTT), glucose level of the D-PGE group was highest at 60 min after administration of glucose but significantly decreased after 180 min. Total lipid and triglyceride contents in serum decreased in the group fed composites compared to the diabetic control group. Especially, total lipid content was lower in the D-PGE, D-JAP1, and D-MET groups, and triglyceride content was lower in the D-PGE and D-JAP2 groups compared to the other groups. HDL-C contents of the D-PGE, D-JAP1 and D-JAP2 groups were significantly increased compared to the diabetic control group. Total lipid, triglyceride and cholesterol contents in liver tissue were significantly lower compared to the diabetic control group. AST, ALT, ALP and γ-GTP activities in serum significantly decreased in groups fed experimental diet compared to the diabetic control group. Especially, the D-JAP2 group had activities among the experimental groups. Hepatic TBARS content was significantly decreased in the D-JAP1 and D-JAP2 groups compared to the diabetic control group. Hepatic antioxidative enzyme SOD, catalase and GSH-Px activities were significantly elevated in groups fed experimental diet compared to the diabetic control group.
The selected optimal composite had hypoglycemic, antidiabetic, and lipid improvement effects compared to H. tuberosus concentrate in diabetes. Therefore, Jerusalem artichoke composite may be useful due to its antioxidant and antidiabetic activities in the human body.

목차

Ⅰ. 서 론 1
Ⅱ. 재료 및 방법 5
1. 실험재료 및 추출물의 제조 5
1) 명월초, 여주, 울금 및 돼지감자 추출물의 제조 5
2) 돼지감자 복합물의 제조 5
2. 이화학적 특성 분석 6
1) 추출 수율 및 pH 측정 6
2) 색도 측정 6
3) 갈색도 측정 6
4) 총당, 환원당 및 이눌린 정량 6
5) 총 페놀 및 플라보노이드 정량 7
3. 생리활성 측정 7
1) 콜레스테롤 흡착활성 측정 7
2) 라디칼 소거활성 측정 7
3) FRAP법에 의한 환원력 측정 8
4) α-Glucosidase 저해활성 측정 8
4. 간 세포를 이용한 항당뇨 활성 측정 8
1) 세포주 배양 8
2) MTT assay에 의한 세포 생존율 측정 9
3) 세포내 당뇨관련 단백질 발현 양상측정(Western blot) 9
4) Glucose uptake 활성 측정 10
5. 실험동물을 이용한 돼지감자 복합물의 항당뇨 활성 10
1) 실험동물의 사양관리 및 처리 10
2) 체중, 식이섭취량 및 식이효율 측정 12
3) 혈당, 인슐린 농도 및 HOMA-IR 측정 12
4) 경구당부하 검사 12
5) 혈청 지질 성분 분석 12
6) 혈청 총 단백질, 알부민 및 글로불린 농도 측정 13
7) AST, ALT, ALP 및 γ-GTP 활성 측정 13
8) 간 조직의 지질 성분 분석 13
9) 간 조직의 지질과산화물 함량 측정 13
10) 혈청 및 간 조직의 항산화 활성 측정 14
11) 간 조직의 항산화효소 활성 측정 14
6. 통계분석 15
Ⅲ. 결과 및 고찰 16
1. 명월초, 여주, 울금 추출물 및 돼지감자 농축액의 이화학적 특성 16
1) 추출물의 고형분 함량 및 pH 16
2) 추출물의 색도 17
3) 추출물의 갈색도 19
4) 추출물의 총당, 환원당 및 이눌린 함량 20
5) 추출물의 총 페놀 및 플라보노이드 함량 21
2. 명월초, 여주 및 울금 추출물과 돼지감자 농축액의 생리활성 22
1) 콜레스테롤 흡착활성 22
2) 라디칼 소거활성 24
(1) DPPH 라디칼 소거활성 24
(2) ABTS 라디칼 소거활성 26
3) FRAP법에 의한 환원력 28
4) α-Glucosidase 저해활성 29
3. 명월초, 여주, 울금 및 돼지감자 복합물의 생리활성 31
1) 라디칼 소거활성 31
2) FRAP법에 의한 환원력 33
3) α-Glucosidase 저해활성 35
4. 간 세포를 이용한 항당뇨 활성 분석 36
1) 명월초, 여주 및 울금 추출물과 돼지감자 농축액의 세포독성 36
2) 돼지감자 복합물에 대한 세포독성 37
3) 돼지감자 복합물에 대한 간 세포의 AMPK 단백질 저해활성 38
4) 돼지감자 복합물에 대한 glucose uptake 활성 40
5. 돼지감자 복합물을 이용한 in vivo 항당뇨 활성 41
1) 실험동물의 체중변화, 식이섭취량 및 식이효율 41
2) 장기 중량 43
3) 혈당, 인슐린 농도 및 HOMA-IR 값 44
4) 혈당 변화 및 경구당부하 검사 46
5) 혈청 지질 성분 48
6) 혈청 총 단백질, 알부민 및 글로불린 농도 51
7) 혈청 AST, ALT, ALP 및 γ-GTP 활성도 52
8) 간 조직의 지질 농도 53
9) 간 조직의 지질과산화물 농도 55
10) 혈청 및 간 조직의 항산화 활성 56
11) 간 조직의 항산화 효소 활성 58
Ⅳ. 요 약 60
Ⅴ. 참고문헌 62

최근 본 자료

전체보기

댓글(0)

0